NASDAQ:ABCL (AbCellera Biologics Inc.)
About ABCL
AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women's health, immunology, and oncology.